Structure-function studies of Bubalus bubalis lingual antimicrobial peptide analogs

Veterinary Research Communications

Volumn 33, Issue 2, 2009, Pages 149-161

  Kalita, Dhruba Jyoti ^a   Kumar, Ashok ^a   Kumar, Satish ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

structure; Antimicrobial peptide; Circular Dichroism spectroscopy; Minimum Inhibitory Concentration

Indexed keywords

LINGUAL ANTIMICROBIAL PEPTIDE [1-26]; LINGUAL ANTIMICROBIAL PEPTIDE [1-64]; LINGUAL ANTIMICROBIAL PEPTIDE [21-64]; LINGUAL ANTIMICROBIAL PEPTIDE [23-55]; LINGUAL ANTIMICROBIAL PEPTIDE [42-64]; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BETA CHAIN; BUFFALO; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SYNTHESIS; ESCHERICHIA COLI; HEMOLYSIS; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; PROTEIN SECONDARY STRUCTURE; QUANTITATIVE ANALYSIS; SALMONELLA TYPHIMURIUM; SOLID PHASE SYNTHESIS; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TONGUE;

AMINO ACID SEQUENCE; ANIMALS; BETA-DEFENSINS; BUFFALOES; CIRCULAR DICHROISM; FLOW CYTOMETRY; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

BUBALUS BUBALIS; ESCHERICHIA COLI; LISTERIA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS;

EID: 59649105462     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-008-9081-7     Document Type: Article

References (44)

1. Ahmed IW., Perkins R., Lupan DM., Selested ME., Janoff AS., 1995. Liposome entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochem. Biophys. Acta. 1237, 109-114. doi: 10.1016/0005-2736(95)00087-J
2. Amsterdam D., 1991. Antibiotics in laboratory Medicine. pp. 72-78, Williams and Wilkins, Baltimore.
3. Anbu KA., T. More, and Ashok Kumar., 2002. Characterization of cationic proteins and peptides from buffalo tongue epithelium. Buffalo J. 2, 211-216
4. Antonyraj P., Antony KJ., Karunakaran T., 2000. Large scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem. J. 347, 633-641. doi: 10.1042/0264-6021:3470633
5. Bello J., Bello HR., Granados E., 1986. Conformational and aggregation of mellitin: Dependence on pH and concentration. Biochem. 21, 461-465.
6. Bessalle R., Haas H., Goria A., Shalit I., Fridkin M., 1992. Augmentation of the antibacterial activity by positive-charge extension. Antimicrob. Agents Chemother. 36, 313-317.
7. Boniotto M., Antcheva N., Zelezetsky I., Toss A., Crovella S., 2003. A study of host defense peptide β-defensin 3 in primates. Biochem. J. 374, 707-714. doi: 10.1042/BJ20030528
8. Cruickshank R., Duguid JP., Marmion BP., Swain RHA., 1975. Medical Microbilogy, Vol. 2. 12th Edition. pp 196. Churchill Livingstone, New York.
9. Dathe M., Wieprecht T., 1999. Structural features of helical antimicrobial peptides: Their potential to modulate activity on model membrane and biological cells. Biochem. Biophysis. Acta. 1462, 71-87. doi: 10.1016/S0005-2736(99)00201-1
10. Dathe M., Nikolenke H., Meyer J., Beyermann M., Biernert M., 2001. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett. 501, 146-150. doi: 10.1016/ S0014-5793(01)02648-5
11. Greenfield NJ., 1996. Methods to estimate the conformation of proteins and polypeptides from circular dichroism data. Analytical. Biochem. 235, 1-10. doi: 10.1006/abio.1996.0084
12. Hancock REW, Chapple DS., 1999. Peptides antibiotics (minireview). Antimicrob. Agents Chemther. 43, 1317-1323.
13. Hirsh DJ., Hammer J., Maloy WL., Blazyk J., Schaefer J., 1996. Secondary structure and location of a magainin analogue in synthetic phospholipids bilayers. Biochem. 35, 12733-12741. doi: 10.1021/bi961468a
14. Hwang PM., Vogel HJ., 1998. Structure function relationships of antimicrobial peptides. Biochem. Cell Biol. 76, 235-246. doi: 10.1139/ bcb-76-2-3-235
15. Javadpour MM., Barkley MD., 1997. Self-assembly of designed antimicrobial activity peptides in solution and micells. Biochem. 36, 9540-9549. doi: 10.1021/bi961644f
16. Jayaraman G., Kumar TKS., Arunkumar A.I., Yu C., 1996. 2,2,2-Trifluroethanol induces helical conformation in all β-sheet protein. Biochem. Biophys. Res. Commun. 222, 33-37. doi: 10.1006/ bbrc.1996.0693
17. Johansson J., Gudmundur H., Gudmundsson, GH, Rottenberg ME., Berndit KD., Agerberth B., 1998. Conformation-dependent antibacterial activity of the naturally occuring human peptide LL-37. J. Biol. Chem. 273, 3718-3724. doi: 10.1074/jbc.273.6.3718
18. Kyngas J., Valjakka J., 1998. Unreliability of Cou-Fasman parameters in predicting protein secondary structure. Pro. Engin. 11, 345-348.
19. Lehrer R., Ganz T., Selested, M., 1991. Defensins: Endogenous antibiotic peptides of animal cells. Cell 64, 229-230.
20. Li SC., Goto NK., Williams KA., Deber CM., 1996. α-helical, but not β-sheet propensity of proline is determined by peptide environment. Proc. Natl. Acad. Sci., USA. 93, 6676-6681. doi: 10.1073/ pnas.93.13.6676
21. Liu D., Degrado F., 2001. De novo design and characterization of antimicrobial β-peptides. J. Am. Chem. Soc. 123, 7533-7539.
22. Matsuyama, K and Natori, S., 1990 Mode of action of sapecin, a novel antibacterial protein of Sarcophaga peregrina (flesh fly). J Biochem. 1081:128-32
23. Matsuzaki K., Murase O., Fujii N., Miyajima K., 1996. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochem. 35, 1361-1368.
24. Matsuzaki K., Yoneyama S., Fujii N., Miyajima K., Yamada K., Kirino Y., Anzali K., 1997. Membrane permeabilization mechanisms of cyclic antimicrobial peptide, tachyplesin1 and its linear analog. Biochem 36, 9799-9806. doi: 10.1021/bi970588v
25. Merrifield RB., 1963. Solid phase peptide synthesis 1. The syntheis of a tetrapeptide. J. Amer.Chem. Soci. 85, 2149-2154. doi: 10.1021/ja00897a025
26. Nannette YY., Jun Y., Alan T., Selested, E., 1999. Cloning and Expression of Bovine Neutrophil β-defensins. J. Bio. Chem. 274, 26249-26258.
27. Nizet Victor, 2006. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 8, 11-26.
28. Pacor S., Giangaspero A., Bacac M., Sava G., Tossi A., 2002. Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: Implications for systemic use. J. Antim. Chem. 50, 339-348. doi: 10.1093/jac/dkf141
29. Panyutich AV., Shi PL., Zhao C., Ganz T., 1997. Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect. Immun. 65, 978-985.
30. Paschel A., 2002. How do bacteria resists human antimicrobial peptides? Trends Microbiol. 10, 179-186. doi: 10.1016/S0966-842X(02)02333-8
31. Roccatano D., Colomo G., Fioroni M., Mark A., 2002. Mechanism by which 2,2,2-trifluroethanol/water mixture stabilizes secondary structure formation in peptides. A molecular dynamics study. Proc. Natl. Acad. Sci., USA. 99, 12179-12184. doi: 10.1073/pnas.182199699
32. Saberwal G., Nagaraj R., 1994. Cell-lytic and antibacterial peptides that act by pertubering the barrier function of membranes: Facets of their conformational features, structure-function co-relations and membrane perturbing abilities. Biochem. Biophys. Acta. 1197, 109-131.
33. Schibli DJ., Hutner NN., Aseyev V., Starner TD., Wiencek JM., McCary PB. Jr, Tack BF., Vogel HJ., 2002. The solution structures of the human β-defensin lead to better understanding of the potent bactericidal activity of HBD3 against Staphyloccus aureus. J. Biol.Chem. 277, 8279-8289. doi: 10.1074/jbc.M108830200
34. Schonwetter BS., Stolzenberg EB., Zasloff, MA., 1995. Epithelial antibiotic induced at sites of inflammation. Science, 262, 1645-1648. doi: 10.1126/science.7886453
35. Scocchi M., Wang S., Zanetti M., 1997. Structural organization of the bovine cathelicidin gene family and identification of a novel member. FEBS Lett. 417, 311-315. doi: 10.1016/S0014-5793(97)01310-0
36. Selested ME., Ouellette AJ., 1995. Defensin in granules of phagocytic and non-phagocytic cells. Trends Cell Biol. 5, 114-119. doi: 10.1016/ S0962-8924(00)88961-8
37. Skerlavaj B., Gennaro R., Bagella L., Merluzzi L., Risso A., Zanetti M., 1996. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J. Biol. Chem., 271, 28375-28381. doi: 10.1074/jbc.271.45.28375
38. Tew NG., Liu D., Chen B., Degrado WF., 2002. De novo design of biomimetic antimicrobial polymers. Proc. Natl. Acad. Sci., USA 99, 5110-5114. doi: 10.1073/pnas.082046199
39. Thomas CJ., Gangadhar BP., Surolia N., Surolia A., 1998. Kinetics and mechanism of the recognition of endotoxin by polymyxin B. J. Amer. Chem. Soc. 120, 12428-12434. doi: 10.1021/ja981777j
40. Verhoef J., 2003 Antibiotic resistance: The pandemic. Adv. Exp. Med. Biol. 531, 301-313.
41. Wang Zhe and Guangshun Wang, 2004. APD: The Antimicrobial peptide database. Nucleic Acid Research. 32, Database issue.
42. Xiao Y., Dai Y., Bommineni YR., Soulages JL., Gong X., Gong Y., Prakash O., Zhang G., 2006. Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken. FEBS J. 273, 2581-2583. doi: 10.1111/j.1742-4658.2006.05261.x
43. Yang JT., Wu CS., Martinez HM., 1986. Calculation of protein conformation from circular dichroism. Methods Enzym. 130, 208-269.
44. Yeaman MR., Yount NY., 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev 55, 27-55. doi: 10.1124/pr.55.1.2